Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryosuke Muroyama

Showing results (11-20 of 58) with videos related to

Pageof 6
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2008
Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patientsRadsamee Sermasathanasawadi, Naoya Kato, Ryosuke Muroyama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replicationChang-Zheng Li, Naoya Kato, Jin-Hai Chang, et al.
Scientific Reports|December 3, 2016
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association studyKaku Goto, Dorcas A Annan, Tomoko Morita, et al.
Journal of Gastroenterology|October 8, 2005
No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell linesRun-Xuan Shao, Motoyuki Otsuka, Naoya Kato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 16, 2013
Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionMasaya Sato, Naoya Kato, Ryosuke Tateishi, et al.
International Journal of Cancer|June 7, 2018
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cellsJun Arai, Kaku Goto, Yasushi Tanoue, et al.
Journal of Gastroenterology|May 22, 2013
IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionMasaya Sato, Naoya Kato, Ryosuke Tateishi, et al.
Anticancer Research|June 23, 2023
PKR-NF-κB Pathway Upstream of IFN-β Induction Is Dysregulated in Oncolytic Sindbis Virus-infected HeLa CellsXue Ma, Tomoko Ogawa, Zheng Tian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatmentJin-Hai Chang, Naoya Kato, Ryosuke Muroyama, et al.
Oncotarget|July 16, 2014
Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICAMotoko Ohno, Motoyuki Otsuka, Takahiro Kishikawa, et al.
Pageof 6

Showing results (11-20 of 58) with videos related to

Sort By:
Pageof 6
Liver International : Official Journal of the International Association for the Study of the Liver|April 10, 2008
Association of interferon regulatory factor-7 gene polymorphism with liver cirrhosis in chronic hepatitis C patientsRadsamee Sermasathanasawadi, Naoya Kato, Ryosuke Muroyama, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 12, 2009
Polymorphism of OAS-1 determines liver fibrosis progression in hepatitis C by reduced ability to inhibit viral replicationChang-Zheng Li, Naoya Kato, Jin-Hai Chang, et al.
Scientific Reports|December 3, 2016
Novel chemoimmunotherapeutic strategy for hepatocellular carcinoma based on a genome-wide association studyKaku Goto, Dorcas A Annan, Tomoko Morita, et al.
Journal of Gastroenterology|October 8, 2005
No mutations in the tyrosine kinases of human hepatic, pancreatic, and gastric cancer cell linesRun-Xuan Shao, Motoyuki Otsuka, Naoya Kato, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|October 16, 2013
Impact of PNPLA3 polymorphisms on the development of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionMasaya Sato, Naoya Kato, Ryosuke Tateishi, et al.
International Journal of Cancer|June 7, 2018
Enzymatic inhibition of MICA sheddase ADAM17 by lomofungin in hepatocellular carcinoma cellsJun Arai, Kaku Goto, Yasushi Tanoue, et al.
Journal of Gastroenterology|May 22, 2013
IL28B minor allele is associated with a younger age of onset of hepatocellular carcinoma in patients with chronic hepatitis C virus infectionMasaya Sato, Naoya Kato, Ryosuke Tateishi, et al.
Anticancer Research|June 23, 2023
PKR-NF-κB Pathway Upstream of IFN-β Induction Is Dysregulated in Oncolytic Sindbis Virus-infected HeLa CellsXue Ma, Tomoko Ogawa, Zheng Tian, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|October 21, 2009
Double-stranded RNA-activated protein kinase inhibits hepatitis C virus replication but may be not essential in interferon treatmentJin-Hai Chang, Naoya Kato, Ryosuke Muroyama, et al.
Oncotarget|July 16, 2014
Specific delivery of microRNA93 into HBV-replicating hepatocytes downregulates protein expression of liver cancer susceptible gene MICAMotoko Ohno, Motoyuki Otsuka, Takahiro Kishikawa, et al.
Pageof 6